Tubeimoside V (TBMS-V) activated EGFR and ITGB1-FAK by regulating caveolin-1 (cav-1)-related signal pathway [272] and finally made TNBC cancer cells sensitive to anoikis and inhibited TNBC cell growth and metastasis [273]. Here, EGFR is linked to cancer.